Researchers analyzed 44 Bundibugyo virus genomes and modeled how approved and experimental Ebola antibodies might bind the ...
AstraZeneca will buy newly issued convertible preferred stock valued at $18.36 per common share, nearly 19% above Monday’s ...
Treatment options for patients with relapsed/refractory follicular lymphoma have expanded rapidly. CD19-directed CAR T-cell therapies are approved in the third-line setting and beyond, and CD20 x CD3 ...
Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...
There is no treatment available today to stop the death of brain cells in neurodegenerative diseases known as tauopathies, ...
An NHS GP has explained how nasal and injected flu vaccines protect children, and how age and certain health conditions ...
Xilio Therapeutics Inc. (Nasdaq: XLO) has appointed Yariv J. Houvras, M.D., Ph.D., as chief medical officer, adding an oncology drug... Read More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results